ATA19972000A - Pibf für die diagnose von tumoren - Google Patents

Pibf für die diagnose von tumoren

Info

Publication number
ATA19972000A
ATA19972000A AT0199700A AT19972000A ATA19972000A AT A19972000 A ATA19972000 A AT A19972000A AT 0199700 A AT0199700 A AT 0199700A AT 19972000 A AT19972000 A AT 19972000A AT A19972000 A ATA19972000 A AT A19972000A
Authority
AT
Austria
Prior art keywords
pibf
tumors
diagnosis
fragment
derivative
Prior art date
Application number
AT0199700A
Other languages
English (en)
Other versions
AT410753B (de
Original Assignee
Cistem Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0199700A priority Critical patent/AT410753B/de
Application filed by Cistem Biotechnologies Gmbh filed Critical Cistem Biotechnologies Gmbh
Priority to CA002431837A priority patent/CA2431837A1/en
Priority to AU2490102A priority patent/AU2490102A/xx
Priority to AU2002224901A priority patent/AU2002224901B2/en
Priority to AT01994744T priority patent/ATE357662T1/de
Priority to PCT/EP2001/013876 priority patent/WO2002044734A1/en
Priority to ES01994744T priority patent/ES2283461T3/es
Priority to EP01994744A priority patent/EP1337850B1/de
Priority to JP2002546225A priority patent/JP4025645B2/ja
Priority to DE60127442T priority patent/DE60127442T2/de
Publication of ATA19972000A publication Critical patent/ATA19972000A/de
Priority to US10/444,693 priority patent/US20040142394A1/en
Application granted granted Critical
Publication of AT410753B publication Critical patent/AT410753B/de
Priority to JP2006043156A priority patent/JP2006230407A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT0199700A 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren AT410753B (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
JP2002546225A JP4025645B2 (ja) 2000-11-28 2001-11-28 Ｐｉｂｆ濃度測定によるガン患者の検査方法
AU2002224901A AU2002224901B2 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of PIBF
AT01994744T ATE357662T1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
PCT/EP2001/013876 WO2002044734A1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf
ES01994744T ES2283461T3 (es) 2000-11-28 2001-11-28 Procedimiento para diagnosticar un tumor en un paciente determinando la concentracion de pibf.
CA002431837A CA2431837A1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf
AU2490102A AU2490102A (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf
DE60127442T DE60127442T2 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
EP01994744A EP1337850B1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
US10/444,693 US20040142394A1 (en) 2000-11-28 2003-05-23 Method for diagnosing a tumor in a patient determining the concentration of PIBF
JP2006043156A JP2006230407A (ja) 2000-11-28 2006-02-20 Ｐｉｂｆ活性をもつタンパク質及びこれをコードする核酸分子

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren

Publications (2)

Publication Number Publication Date
ATA19972000A true ATA19972000A (de) 2002-12-15
AT410753B AT410753B (de) 2003-07-25

Family

ID=3689570

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
AT01994744T ATE357662T1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01994744T ATE357662T1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Country Status (9)

Country Link
US (1) US20040142394A1 (de)
EP (1) EP1337850B1 (de)
JP (2) JP4025645B2 (de)
AT (2) AT410753B (de)
AU (2) AU2002224901B2 (de)
CA (1) CA2431837A1 (de)
DE (1) DE60127442T2 (de)
ES (1) ES2283461T3 (de)
WO (1) WO2002044734A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA8092002A (de) * 2002-05-28 2005-01-15 Intercell Ag Pibf
JP2015109806A (ja) * 2012-03-22 2015-06-18 アステラス製薬株式会社 新規ｒｅｔ融合体の検出法
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108447537A (zh) * 2018-03-23 2018-08-24 广西科技大学 一种妊娠期及哺乳期妇女用药安全和健康管理系统
KR102490714B1 (ko) * 2018-12-28 2023-01-26 재단법인 아산사회복지재단 Pibf 단백질을 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5646003A (en) * 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
WO1999014372A1 (en) * 1997-09-15 1999-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
ATE383866T1 (de) * 1998-07-02 2008-02-15 Envision Biomedical Consulting Antiproliferative und antivirale proteine und peptide
AU7854400A (en) * 1999-10-08 2001-04-23 Envision Biomedical Consulting Gestational agents which modulate cell proliferation

Also Published As

Publication number Publication date
US20040142394A1 (en) 2004-07-22
DE60127442D1 (de) 2007-05-03
JP2006230407A (ja) 2006-09-07
AT410753B (de) 2003-07-25
EP1337850A1 (de) 2003-08-27
AU2002224901B2 (en) 2006-11-09
ATE357662T1 (de) 2007-04-15
WO2002044734A1 (en) 2002-06-06
JP2004514909A (ja) 2004-05-20
JP4025645B2 (ja) 2007-12-26
CA2431837A1 (en) 2002-06-06
DE60127442T2 (de) 2007-11-29
ES2283461T3 (es) 2007-11-01
EP1337850B1 (de) 2007-03-21
AU2490102A (en) 2002-06-11

Similar Documents

Publication Publication Date Title
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
ATE337011T1 (de) Modifizierte psma-liganden und deren verwendung
DE60326214D1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
DK1975231T3 (da) Sammensætninger og fremgangsmåder til detektion, diagnose og terapi af hæmatologiske sygdomme
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
DE60237531D1 (de) Verfahren zum trennen von seltenen zellen von fluidproben
WO2004090550A3 (en) A method for detection of colorectal cancer in human samples
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2004021008A3 (en) Methods for detecting breast and ovarian cancer
ATE282831T1 (de) Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
DE60326153D1 (de) Verfahren zur diagnose von morbus alzheimer
ATE323781T1 (de) Diagnostischer test für die alzheimersche krankheit
WO2003044485A3 (en) Proteonomic methods for diagnosis and monitoring of breast cancer
ATE272214T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von s100b
ATA19972000A (de) Pibf für die diagnose von tumoren
DE60126248D1 (de) Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
ATE293794T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 125
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
HUP0101285A2 (hu) Eljárások és készítmények a hepatóma diagnosztizálására
ATE327766T1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee